PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjThe BMJ
 
BMJ. 1996 November 30; 313(7069): 1362–1366.
PMCID: PMC2352912

Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial.

Abstract

OBJECTIVE: To study the effects of prolonged intake of cafetière coffee, which is rich in the diterpenes cafestol and kahweol, on serum aminotransferase and lipid concentrations. DESIGN: Randomised parallel controlled trial. SUBJECTS: 46 healthy men and women aged 19 to 69. INTERVENTION: Consumption of five to six strong cups (0.9 litres) a day of either cafetière (22 subjects) or filtered coffee (24 subjects) for 24 weeks. MAIN OUTCOME MEASURES: Mean changes in serum aminotransferase and lipid concentrations. RESULTS: Cafetière coffee raised alanine aminotransferase concentration by up to 80% above baseline values relative to filtered coffee. After 24 weeks the rise was still 45% (9 U/l (95% confidence interval 3 to 15 U/l), P = 0.007). Alanine aminotransferase concentration exceeded the upper limit of normal in eight of the 22 subjects drinking cafetière coffee, being twice the upper limit of normal in three of them. Cafetière coffee raised low density lipoprotein cholesterol concentrations by 9-14%. After 24 weeks the rise was 0.26 mmol/l (0.04 to 0.47 mmol/l) (P = 0.03) relative to filtered coffee. Triglyceride concentrations initially rose by 26% with cafetière coffee but returned close to baseline values within six months. All increases were reversible after the intervention was stopped. CONCLUSIONS: Daily consumption of five to six cups of strong cafetière coffee affects the integrity of liver cells as suggested by small increases in serum alanine aminotransferase concentration. The effect does not subside with prolonged intake. High intakes of coffee brews rich in cafestol and kahweol may thus be responsible for unexplained increases in this enzyme activity in apparently healthy subjects. Cafetière coffee also raises low density lipoprotein cholesterol concentration and thus the risk of coronary heart disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Thelle DS, Arnesen E, Førde OH. The Tromsø heart study. Does coffee raise serum cholesterol? N Engl J Med. 1983 Jun 16;308(24):1454–1457. [PubMed]
  • Aro A, Tuomilehto J, Kostiainen E, Uusitalo U, Pietinen P. Boiled coffee increases serum low density lipoprotein concentration. Metabolism. 1987 Nov;36(11):1027–1030. [PubMed]
  • Aro A, Teirilä J, Gref CG. Dose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee. Atherosclerosis. 1990 Aug;83(2-3):257–261. [PubMed]
  • Bak AA, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med. 1989 Nov 23;321(21):1432–1437. [PubMed]
  • Weusten-Van der Wouw MP, Katan MB, Viani R, Huggett AC, Liardon R, Liardon R, Lund-Larsen PG, Thelle DS, Ahola I, Aro A, et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res. 1994 Apr;35:721–733. [PubMed]
  • Heckers H, Göbel U, Kleppel U. End of the coffee mystery: diterpene alcohols raise serum low-density lipoprotein cholesterol and triglyceride levels. J Intern Med. 1994 Feb;235(2):192–193. [PubMed]
  • van Rooij J, van der Stegen GH, Schoemaker RC, Kroon C, Burggraaf J, Hollaar L, Vroon TF, Smelt AH, Cohen AF. A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee. Am J Clin Nutr. 1995 Jun;61(6):1277–1283. [PubMed]
  • Urgert R, Schulz AG, Katan MB. Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr. 1995 Jan;61(1):149–154. [PubMed]
  • Smith SC., Jr AHA president's letter. Circulation. 1995 Jul 1;92(1):1–1. [PubMed]
  • Feunekes GI, Van Staveren WA, De Vries JH, Burema J, Hautvast JG. Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr. 1993 Oct;58(4):489–496. [PubMed]
  • Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem. 1978 Jan;24(1):58–73. [PubMed]
  • Bowers GN, Jr, McComb RB. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin Chem. 1966 Feb;12(2):70–89. [PubMed]
  • Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem. 1969 Feb;15(2):124–136. [PubMed]
  • Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983 Jun;29(6):1075–1080. [PubMed]
  • Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982 Jun;28(6):1379–1388. [PubMed]
  • Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982 Oct;28(10):2077–2080. [PubMed]
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed]
  • Nilssen O, Førde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. Am J Epidemiol. 1994 Apr 15;139(8):787–792. [PubMed]
  • La Vecchia C, Levi F, Lucchini F, Franceschi S, Negri E. Worldwide patterns and trends in mortality from liver cirrhosis, 1955 to 1990. Ann Epidemiol. 1994 Nov;4(6):480–486. [PubMed]
  • Bønaa K, Arnesen E, Thelle DS, Førde OH. Coffee and cholesterol: is it all in the brewing? The Tromsø Study. BMJ. 1988 Oct 29;297(6656):1103–1104. [PMC free article] [PubMed]
  • Lindahl B, Johansson I, Huhtasaari F, Hallmans G, Asplund K. Coffee drinking and blood cholesterol--effects of brewing method, food intake and life style. J Intern Med. 1991 Oct;230(4):299–305. [PubMed]
  • Pietinen P, Aro A, Tuomilehto J, Uusitalo U, Korhonen H. Consumption of boiled coffee is correlated with serum cholesterol in Finland. Int J Epidemiol. 1990 Sep;19(3):586–590. [PubMed]
  • Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol. 1989;42(9):877–884. [PubMed]
  • Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ. 1990 Mar 3;300(6724):566–569. [PMC free article] [PubMed]
  • Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994 Feb 5;308(6925):367–372. [PMC free article] [PubMed]
  • Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR, Jr, O'Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993 Apr 29;328(17):1220–1225. [PubMed]
  • Zock PL, Katan MB, Mensink RP. Dietary trans fatty acids and lipoprotein cholesterol. Am J Clin Nutr. 1995 Mar;61(3):617–617. [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group